Fusi CP Cream is a topical medication combining Clobetasol propionate (0.05% w/w), a potent corticosteroid, and Fusidic Acid (2% w/w), a bacteriostatic antibiotic, formulated to treat inflammatory skin conditions complicated by bacterial infections. Clobetasol propionate works by reducing inflammation, redness, and itching through its strong anti-inflammatory and immunosuppressive effects, while Fusidic Acid targets susceptible bacteria by inhibiting bacterial protein synthesis, thereby preventing the growth and spread of infection. This dual-action cream is particularly effective in managing conditions such as infected eczema, psoriasis, and dermatitis where inflammation and bacterial colonization coexist. Fusi CP Cream should be applied in a thin layer to the affected area once or twice daily as directed by a healthcare professional. It is intended for short-term use due to the potency of Clobetasol, and prolonged application may lead to side effects such as skin thinning, irritation, or systemic absorption. Patients should avoid contact with eyes and mucous membranes and discontinue use if signs of hypersensitivity occur. As with all corticosteroid-containing products, it is essential to follow medical advice closely to ensure safe and effective treatment outcomes.